SGB Closes Second Capital Raise to Fund National Expansion

By late 2023, Supergalactic Brands had enough proof points to tell a different story to investors. The 2021 raise funded the science. The 2023 raise funded the scale. Colorado wholesale revenue had grown 5,000%. Sano Gardens had taken Grand Champion at the Rooster THC Classic. TTS nano-emulsification was live across multiple SKUs. The platform worked. The second raise was about taking it national.

What Changed Between Raises

In 2021, SGB was asking investors to bet on science that hadn't yet reached retail. In 2023, SGB had a track record: award-winning products, 200+ dispensary relationships in Colorado, and a hemp-derived product line that operated nationally under the 2018 Farm Bill. The risk profile had changed fundamentally.

The first raise built the lab. The second raise built the distribution infrastructure to take what came out of it to 50 states.

The Expansion Strategy

The 2023 capital enabled several simultaneous moves: the acquisition of SUM Microdose from KelSci Biotech, the expansion of Orchard and Herb and Lou's into new states through United States Beverage, the development of Zingiez as a standalone brand, and the licensing agreement with MRM to enter the Massachusetts regulated market. One raise. Multiple vectors of expansion.

Where the Capital Goes Next

SGB is positioned for a third chapter — one that takes the national hemp platform into institutional retail, builds the DTC infrastructure across all brands, and scales the QCi Labs manufacturing arm to meet demand that's currently being deferred. The story for the next raise is already being written by the results of the last one.

Supergalactic Brands · Second capital raise 2023 · National expansion